In Wallonia, on 1 March Tuesday, the distribution of the Novavax vaccine for COVID-19 will start on 5 March.
As per the information provided by the office of Walloon Health Minister Christie Morreale, an effective vaccine against COVID-19, the 150,000 doses of this fifth vaccine authorised in Belgium should be sufficient to be vaccinated nearly 75,000 of grown-ups.
Moreover, seven of the vaccination centres in the five of the Walloon provinces will use this new vaccine, which will be administered first to the individuals with a high risk of several allergic reactions to polyethylene glycol (PEG), which can be discovered in different COVID vaccines.
Along with this, people who experienced a severe adverse response to the first or second dose of the other vaccination against COVID-19 are another priority category.
Additionally, they will be able to have their jabs at an allergy centre, but with the agreement of the attending physician, they may also go to a vaccination clinic.
The third priority group is health professionals who are not vaccinated or have only received the initial dose of Pfizer, AstraZeneca and Moderna.
However, once these priorities groups have the chance to get the vaccination, the remaining shots will be provided on the appointment to anyone who has already started their vaccine course with the other brands of the vaccinations.
On Tuesday, Brussels began its immunisation campaign with this serum, which employs a more “traditional” method based on recombinant proteins, similar to that used in many other vaccinations, such as the hepatitis B vaccine. It is given in two doses with a three-week break between them.
